(1)
Evaluation Model of the Effect of Rofecoxib on the Co-Prescription of Gastroprotective Agents Observed During the Treatment of Ostheoarthritis. Reumatismo 2002, 54 (4), 331-339. https://doi.org/10.4081/reumatismo.2002.331.